| For: | Tan BB, Fu Y, Shao MH, Chen HL, Liu P, Fan C, Zhang H. Combined transarterial chemoembolization and tislelizumab for patients with unresectable hepatocellular carcinoma. World J Gastrointest Surg 2024; 16(9): 2829-2841 [PMID: 39351562 DOI: 10.4240/wjgs.v16.i9.2829] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v16/i9/2829.htm |
| Number | Citing Articles |
| 1 |
Yi Yu, Wei Yuan, Jin Lei, Chun-Bo Zhao, Cheng-Gang Tao, Sheng-Hui Liu, Bai-Lin Wang. Synchronous <i>vs</i> sequential combination of transarterial chemoembolization and microwave ablation for hepatocellular carcinoma: Efficacy and prognosis. World Journal of Gastrointestinal Surgery 2026; 18(2): 114378 doi: 10.4240/wjgs.v18.i2.114378
|
| 2 |
Yang-Yang Fu, Wen-Mao Li, Hong-Qiao Cai, Yan Jiao. Landscape of transarterial chemoembolization represented interventional therapy for hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2024; 16(12): 3903-3906 doi: 10.4240/wjgs.v16.i12.3903
|
